imidazole-4-carboxamide has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Alessandro-Gabazza, CN; Fridman D'Alessandro, V; Fujimoto, H; Gabazza, EC; Inoue, C; Inoue, R; Kawagishi, H; Kobayashi, T; Kobori, H; Nishihama, K; Okano, Y; Takeshita, A; Tharavecharak, S; Toda, M; Wu, J; Yano, Y; Yasuma, T | 1 |
1 other study(ies) available for imidazole-4-carboxamide and Malignant Melanoma
| Article | Year |
|---|---|
The Fairy Chemical Imidazole-4-carboxamide Inhibits the Expression of Axl, PD-L1, and PD-L2 and Improves Response to Cisplatin in Melanoma.
Topics: Aminoimidazole Carboxamide; Animals; B7-H1 Antigen; Cisplatin; Humans; Immune Checkpoint Proteins; Melanoma; Mice | 2022 |